Bio-Rad Laboratories, Inc.

NYSE (USD): Bio-Rad Laboratories, Inc. (BIO)

Last Price

356.57

Today's Change

+25.99 (7.86%)

Day's Change

340.00 - 358.96

Trading Volume

142,799

Overview

Market Cap

9 Billion

Shares Outstanding

27 Million

Avg Volume

296,817

Avg Price (50 Days)

331.50

Avg Price (200 Days)

314.63

PE Ratio

-7.53

EPS

-47.33

Earnings Announcement

30-Oct-2024

Previous Close

330.58

Open

348.47

Day's Range

340.0 - 358.96

Year Range

262.12 - 364.24

Trading Volume

143,074

Price Change Highlight

1 Day Change

7.86%

5 Day Change

8.54%

1 Month Change

6.57%

3 Month Change

5.38%

6 Month Change

32.19%

Ytd Change

8.71%

1 Year Change

29.53%

3 Year Change

-54.53%

5 Year Change

7.52%

10 Year Change

216.05%

Max Change

13903.48%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment